Block on Trump's Asylum Ban Upheld by Supreme Court
A national registry of Accutane users began accepting names on December 30, 2005. The iPLEDGE program, intended to keep track of persons currently using the anti-acne drug, requires health care providers and pharmacists to identify all patients who have been prescribed and/or sold Accutane, or any generic version of the drug (isotretinoin). The goal of the registry is to reduce the incidence of pregnancy-related harm caused by the drug, including birth defects and birth injuries.
Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.